3SBio Inc
HKEX:1530

Watchlist Manager
3SBio Inc Logo
3SBio Inc
HKEX:1530
Watchlist
Price: 12.4 HKD 5.26% Market Closed
Market Cap: 29.7B HKD

P/E
Price to Earnings

13.4
Current
8.1
Median
22
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
13.4
=
Market Cap
29.7B HKD
/
Net Income
2.1B CNY
Market Cap P/E
CN
3SBio Inc
HKEX:1530
29.7B HKD 13.4
FR
Pharnext SCA
OTC:PNEXF
6T USD -167 520.3
US
Abbvie Inc
NYSE:ABBV
309B USD 72.9
US
Amgen Inc
NASDAQ:AMGN
153.7B USD 37.6
US
Gilead Sciences Inc
NASDAQ:GILD
129.1B USD 269
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
124.4B USD -232.3
US
Epizyme Inc
F:EPE
94.1B EUR -510
AU
CSL Ltd
ASX:CSL
111.4B AUD 25.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
60.7B USD 13.8
US
Seagen Inc
F:SGT
39.3B EUR -59
NL
argenx SE
XBRU:ARGX
29.2B EUR 39.4
Earnings Growth PEG
CN
3SBio Inc
HKEX:1530
Average P/E: 67.4
13.4
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -167 520.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
72.9
87%
0.8
US
Amgen Inc
NASDAQ:AMGN
37.6
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
269
187%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -232.3 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -510 N/A N/A
AU
CSL Ltd
ASX:CSL
25.5
16%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.8
12%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A N/A
NL
argenx SE
XBRU:ARGX
39.4
26%
1.5

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
12.1
2-Years Forward
P/E
11.3
3-Years Forward
P/E
N/A